Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 25

Trial Status

Completed4
Terminated1

Role Distribution

Principal Investigator5
PI Rate100%

Activity Timeline

Clinical Trials (5)

NCT02399371Phase 2Completed
Pembrolizumab in Treating Patients With Malignant Mesothelioma
Biphasic MesotheliomaEpithelioid MesotheliomaPeritoneal Malignant Mesothelioma+7 more
PrincipalinvestigatorStart date: 2015-03-31
NCT00023946Phase 2Terminated
BMS-247550 in Treating Patients With Liver or Gallbladder Cancer
Adult Primary Cholangiocellular CarcinomaAdult Primary Hepatocellular CarcinomaAdvanced Adult Primary Liver Cancer+11 more
Principalinvestigator
NCT00027703Phase 2Completed
Combination Chemotherapy With or Without Bevacizumab in Treating Patients With Malignant Mesothelioma
Advanced Malignant MesotheliomaEpithelial MesotheliomaLocalized Malignant Mesothelioma+2 more
Principalinvestigator
NCT00091026Phase 2Completed
Bevacizumab and Gemcitabine Combined With Either Cetuximab or Erlotinib in Treating Patients With Advanced Pancreatic Cancer
Adenocarcinoma of the PancreasRecurrent Pancreatic CancerStage II Pancreatic Cancer+2 more
Principalinvestigator
NCT00504153Phase 2Completed
Dasatinib in Treating Patients With Previously Treated Metastatic Colorectal Cancer
Recurrent Colon CancerRecurrent Rectal CancerStage IV Colon Cancer+1 more
Principalinvestigator

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Stephen Michael Hahn

Abramson Cancer Center at Penn Medicine

Related
6 trials

Shared therapeutic areas:

Advanced Adult Primary Liver CancerAdvanced Malignant MesotheliomaLocalized Extrahepatic Bile Duct Cancer+18 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score17%

Hedy Kindler

University of Chicago Comprehensive Cancer Center

Related
6 trials

Shared therapeutic areas:

Stage III Pancreatic CancerStage IV Pancreatic CancerAdenocarcinoma of the Pancreas+15 more

Worked with same sponsors:

National Cancer Institute (NCI)University of Chicago
Similarity Score14%

Caio Rocha Lima, MD

Wake Forest University Health Sciences

Related
4 trials

Shared therapeutic areas:

Recurrent Pancreatic CancerStage IV Pancreatic CancerAdult Primary Cholangiocellular Carcinoma+10 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score10%

Antonius Miller

Cancer and Leukemia Group B

Related
3 trials

Shared therapeutic areas:

Adult Primary Hepatocellular CarcinomaAdvanced Adult Primary Liver CancerAdvanced Malignant Mesothelioma+10 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score10%

Tanios Bekaii-Saab

Ohio State University

Related
3 trials

Shared therapeutic areas:

Recurrent Extrahepatic Bile Duct CancerUnresectable Extrahepatic Bile Duct CancerAdult Primary Cholangiocellular Carcinoma+4 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score6%

Vincent Chung, MD

City of Hope Medical Center

Related
6 trials

Shared therapeutic areas:

Recurrent Colon CancerRecurrent Pancreatic CancerRecurrent Rectal Cancer+4 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score6%

Wen Wee Ma

Roswell Park Cancer Institute

Related
5 trials

Shared therapeutic areas:

Stage IV Pancreatic CancerRecurrent Pancreatic CancerStage III Pancreatic Cancer+2 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score4%

Betty Ferrell

City of Hope Medical Center

Related
5 trials

Shared therapeutic areas:

Recurrent Colon CancerRecurrent Pancreatic CancerRecurrent Rectal Cancer+2 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score4%

Joshua Meyer, MD

Fox Chase Cancer Center

Related
8 trials

Shared therapeutic areas:

Adult Primary Hepatocellular CarcinomaAdvanced Adult Primary Liver CancerRecurrent Adult Primary Liver Cancer+1 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score3%

Sanjiv Gambhir, MD, PhD

Stanford University

Related
3 trials

Shared therapeutic areas:

Recurrent Colon CancerRecurrent Pancreatic CancerRecurrent Rectal Cancer+1 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score3%

Publications (0)

No publications found for this investigator.

Clinical Trials (5)

Showing 5 of 5 trials

NCT02399371Phase 2PrincipalInvestigator

Pembrolizumab in Treating Patients With Malignant Mesothelioma

Biphasic MesotheliomaEpithelioid MesotheliomaPeritoneal Malignant Mesothelioma+7 more
Completed
NCT00023946Phase 2PrincipalInvestigator

BMS-247550 in Treating Patients With Liver or Gallbladder Cancer

Adult Primary Cholangiocellular CarcinomaAdult Primary Hepatocellular CarcinomaAdvanced Adult Primary Liver Cancer+11 more
Terminated
NCT00027703Phase 2PrincipalInvestigator

Combination Chemotherapy With or Without Bevacizumab in Treating Patients With Malignant Mesothelioma

Advanced Malignant MesotheliomaEpithelial MesotheliomaLocalized Malignant Mesothelioma+2 more
Completed
NCT00091026Phase 2PrincipalInvestigator

Bevacizumab and Gemcitabine Combined With Either Cetuximab or Erlotinib in Treating Patients With Advanced Pancreatic Cancer

Adenocarcinoma of the PancreasRecurrent Pancreatic CancerStage II Pancreatic Cancer+2 more
Completed
NCT00504153Phase 2PrincipalInvestigator

Dasatinib in Treating Patients With Previously Treated Metastatic Colorectal Cancer

Recurrent Colon CancerRecurrent Rectal CancerStage IV Colon Cancer+1 more
Completed

All 5 trials loaded